Multicenter Investigation of Limitation of Infarct Size (MILIS)

• Status: Completed
• Trial end date: 1985-12-01
• Target enrollment: 0
• Participant gender: All

Summary

To assess the ability of two separate therapeutic interventions, propranolol and hyaluronidase, to limit the ultimate size of an acute myocardial infarction. A secondary objective was to assess the influence of these therapies upon ventricular function and morbidity following myocardial infarction.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
• Treatments: Propranolol

Criteria

Men and women, under age 75. Documented myocardial infarction which could be treated within 18 hours of onset of ischemic symptoms.